• What We Do
  • Who We Are
  • Simulations
  • Presentations & Research
  • Contact Us
  • White Paper
  • Disclaimer
  • Industry Sector
  • Global Region
  • ETF's and Futures
  • Major Funds - Holding
  • Tutorial
  • Best Risk Adjusted
  • Worst Risk Adjusted
  • Best Expected
  • Worst Expected
  • Sector Ranking
  • Dividend
  • REIT's
  • Leverage Risk
  • Convertible Bonds
  • Investment Grade
  • High Yield
  • ADR
  • Small Caps
Rational Investing
  • About Usarrow_drop_down
  • Coveragearrow_drop_down
  • Returnsarrow_drop_down
  • Productarrow_drop_down


Diagnostic Substances

       Total Market Capitalization of All Firms 20504 mm             
       Average Market Capitalization 5126 mm       
       Average Market to Model Ratio Weighted by Log of Market Cap 1.70       
       Standard Deviation of MM Ratio 0       
       Average Beta 1.02       
       Average EV To Revenue 5.27       
       Average Price To Free Cash Flow 42.2       

TickerCompany NameMarket To ModelMarket Cap ($ mm)EV to RevenuePrice To FCF% GrowthBetaAs Of
NEOGNeogen Corp.2.53,3307.954.621.34Aug 19
IDXXIdexx Laboratories Inc.1.714,2206.275.7100.81Sep 19
QDELQuidel Corp.1.72,5804.926.761.37Sep 19
VIVOMeridian Bioscience Inc.0.63732.111.8-70.58Mar 19
Standard Value | About us | Contact us     Copyright © 2003-2019 Rational Investing LLC ® | All Rights Reserved